---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-002023"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T07:00:31.768191+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TriSalus promotes James Young to CFO; appoints new CCO and Chief of Clinical Operations

## Summary
- James Young promoted to CFO, effective Jan 6, 2025; annual base salary $420k, target bonus 50%.
- Sean Murphy transitions to Chief Manufacturing, Strategy and Business Development Officer; remains on board.
- Richard Marshak appointed Chief Commercial Officer; Jodi Devlin appointed Chief of Clinical Operations.
- Executive officers elected to forgo $515k in salary for RSUs under new Salary Investment Program.

## SEC filing metadata
- accession: 0001104659-25-002023
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465925002023/0001104659-25-002023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465925002023/tm252133d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-002023
- JSON: https://secwatch.observer/filing/0001104659-25-002023.json
- Plain text: https://secwatch.observer/filing/0001104659-25-002023.txt

## Key facts
- Executive change
  James Young changed role as Chief Financial Officer at TriSalus Life Sciences, Inc..
  - Action: promoted
  - Role: Chief Financial Officer
  source text: promoting James Young to Chief Financial Officer, Secretary, Treasurer and principal financial and accounting officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465925002023/0001104659-25-002023-index.htm
- Executive change
  Sean Murphy was appointed as Chief Manufacturing, Strategy and Business Development Officer at TriSalus Life Sciences, Inc..
  - Action: appointed
  - Role: Chief Manufacturing, Strategy and Business Development Officer
  source text: appointing Sean Murphy to Chief Manufacturing, Strategy and Business Development Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465925002023/0001104659-25-002023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.